Changing the Paradigm (ASX:PAR): Revolutionising Osteoarthritis Management
December 14, 202334m 18s
Audio is streamed directly from the publisher (traffic.megaphone.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Justin talks with Paul Rennie, CEO of late-stage drug development company Paradigm Biopharmaceutics (ASX:PAR).
Learn more about your ad choices. Visit megaphone.fm/adchoices